id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02465268
|
71:83:treatment
|
History & physical with neurologic examination prior to initiation of adjuvant TMZ
| 3
|
[
"History",
"&",
"physical",
"with",
"neurologic",
"examination",
"prior",
"to",
"initiation",
"of",
"adjuvant",
"TMZ"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02128906
|
74:97:treatment
|
Appropriate studies will be undertaken in patients receiving combination anti-retroviral therapy when indicated
| 3
|
[
"Appropriate",
"studies",
"will",
"be",
"undertaken",
"in",
"patients",
"receiving",
"combination",
"anti-retroviral",
"therapy",
"when",
"indicated"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02172651
|
49:76:cancer,116:134:cancer,,,172:211:treatment
|
Participants must have histologically confirmed adenocarcinoma of the colon that is localized, with no evidence of distant metastasis (stage I, II, or III), and for which surgical resection of the primary tumor is being planned
| 3
|
[
"Participants",
"must",
"have",
"histologically",
"confirmed",
"adenocarcinoma",
"of",
"the",
"colon",
"that",
"is",
"localized",
",",
"with",
"no",
"evidence",
"of",
"distant",
"metastasis",
"(",
"stage",
"I",
",",
"II",
",",
"or",
"III",
")",
",",
"and",
"for",
"which",
"surgical",
"resection",
"of",
"the",
"primary",
"tumor",
"is",
"being",
"planned"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0
] |
NCT02089607
|
1:48:treatment,,95:125:treatment,210:230:treatment,232:252:treatment,254:275:treatment,318:425:treatment,438:459:treatment,461:478:treatment,482:497:treatment,536:553:chronic_disease
|
Prior open surgical or interventional procedure within 30 days of the anticipated date of the fenestrated-branched procedure, with the exception of planned staged procedures to provide access for repair (e.g. staged iliac conduit, cervical debranching, elephant trunk repair), to facilitate the procedure by allowing open revascularization of a target artery not amenable to revascularization with the investigational device, such as an internal iliac artery, subclavian artery or visceral artery with early bifurcation, tortuosity or occlusive disease preventing successful placement of alignment side stents
| 3
|
[
"Prior",
"open",
"surgical",
"or",
"interventional",
"procedure",
"within",
"30",
"days",
"of",
"the",
"anticipated",
"date",
"of",
"the",
"fenestrated-branched",
"procedure",
",",
"with",
"the",
"exception",
"of",
"planned",
"staged",
"procedures",
"to",
"provide",
"access",
"for",
"repair",
"(",
"e.g",
".",
"staged",
"iliac",
"conduit",
",",
"cervical",
"debranching",
",",
"elephant",
"trunk",
"repair",
")",
",",
"to",
"facilitate",
"the",
"procedure",
"by",
"allowing",
"open",
"revascularization",
"of",
"a",
"target",
"artery",
"not",
"amenable",
"to",
"revascularization",
"with",
"the",
"investigational",
"device",
",",
"such",
"as",
"an",
"internal",
"iliac",
"artery",
",",
"subclavian",
"artery",
"or",
"visceral",
"artery",
"with",
"early",
"bifurcation",
",",
"tortuosity",
"or",
"occlusive",
"disease",
"preventing",
"successful",
"placement",
"of",
"alignment",
"side",
"stents"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573493
|
23:47:cancer
|
Diagnosis of selected Stage III or IVa/b HNSCC
| 3
|
[
"Diagnosis",
"of",
"selected",
"Stage",
"III",
"or",
"IVa/b",
"HNSCC"
] |
[
0,
0,
0,
3,
3,
3,
3,
3
] |
NCT02960555
|
1:14:chronic_disease,,,,,
|
Hypercalcemia: serum calcium > 0.25 mmol/L (> 1 mg/dL) higher than the upper limit of normal or > 2.75 mmol/L (> 11 mg/dL)
| 3
|
[
"Hypercalcemia",
":",
"serum",
"calcium",
">",
"0.25",
"mmol/L",
"(",
">",
"1",
"mg/dL",
")",
"higher",
"than",
"the",
"upper",
"limit",
"of",
"normal",
"or",
">",
"2.75",
"mmol/L",
"(",
">",
"11",
"mg/dL",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02356653
|
1:51:chronic_disease
|
Uncontrolled bacterial, viral or fungal infections
| 3
|
[
"Uncontrolled",
"bacterial",
",",
"viral",
"or",
"fungal",
"infections"
] |
[
2,
2,
2,
2,
2,
2,
0
] |
NCT00906984
|
,14:33:treatment
|
> 30 Gy over multiple treatments
| 3
|
[
">",
"30",
"Gy",
"over",
"multiple",
"treatments"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02517307
|
18:22:treatment
|
regularly taking meds that strongly affect bleeding, bruising or platelets
| 3
|
[
"regularly",
"taking",
"meds",
"that",
"strongly",
"affect",
"bleeding",
",",
"bruising",
"or",
"platelets"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02485418
|
4:10:treatment,
|
No opioid within 2 hours
| 3
|
[
"No",
"opioid",
"within",
"2",
"hours"
] |
[
0,
1,
0,
0,
0
] |
NCT02581384
|
7:44:treatment,,
|
Prior whole-lung or hemi-thorax irradiation of greater than 12 Gy received less than 6 months prior to consent
| 3
|
[
"Prior",
"whole-lung",
"or",
"hemi-thorax",
"irradiation",
"of",
"greater",
"than",
"12",
"Gy",
"received",
"less",
"than",
"6",
"months",
"prior",
"to",
"consent"
] |
[
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02110992
|
1:20:cancer
|
noninvasive cancers are permitted
| 3
|
[
"noninvasive",
"cancers",
"are",
"permitted"
] |
[
3,
3,
0,
0
] |
NCT01966367
|
10:24:chronic_disease
|
Adequate liver function per protocol
| 3
|
[
"Adequate",
"liver",
"function",
"per",
"protocol"
] |
[
0,
2,
2,
0,
0
] |
NCT01923662
|
12:22:chronic_disease
|
Controlled spasticity and absence of hip flexion and adduction spasms
| 3
|
[
"Controlled",
"spasticity",
"and",
"absence",
"of",
"hip",
"flexion",
"and",
"adduction",
"spasms"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02844907
|
22:33:treatment,80:95:treatment,97:110:treatment,112:121:treatment,123:137:treatment
|
Consumption of daily medications that alter glucose metabolism of GI function (glucocorticoids, psychotropics, narcotics, metoclopramide)
| 3
|
[
"Consumption",
"of",
"daily",
"medications",
"that",
"alter",
"glucose",
"metabolism",
"of",
"GI",
"function",
"(",
"glucocorticoids",
",",
"psychotropics",
",",
"narcotics",
",",
"metoclopramide",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT01505569
|
31:44:cancer,,,
|
Patients with newly diagnosed neuroblastoma with INSS Stage 2A/2B with MYCN amplification (> 4-fold increase in MYCN signals as compared to reference signals), regardless of age or additional biologic features
| 3
|
[
"Patients",
"with",
"newly",
"diagnosed",
"neuroblastoma",
"with",
"INSS",
"Stage",
"2A/2B",
"with",
"MYCN",
"amplification",
"(",
">",
"4-fold",
"increase",
"in",
"MYCN",
"signals",
"as",
"compared",
"to",
"reference",
"signals",
")",
",",
"regardless",
"of",
"age",
"or",
"additional",
"biologic",
"features"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01538966
|
17:29:treatment,
|
The patient had radiotherapy within 12 months prior to study entry
| 3
|
[
"The",
"patient",
"had",
"radiotherapy",
"within",
"12",
"months",
"prior",
"to",
"study",
"entry"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02407171
|
,75:92:cancer,
|
2 or more measurable sites of disease as defined by either RECIST 1.1, or cutaneous lesions at least 1 cm in greatest dimension
| 3
|
[
"2",
"or",
"more",
"measurable",
"sites",
"of",
"disease",
"as",
"defined",
"by",
"either",
"RECIST",
"1.1",
",",
"or",
"cutaneous",
"lesions",
"at",
"least",
"1",
"cm",
"in",
"greatest",
"dimension"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02589977
|
21:32:chronic_disease
|
significant cardiac arrhythmias
| 3
|
[
"significant",
"cardiac",
"arrhythmias"
] |
[
0,
0,
2
] |
NCT01415752
|
4:17:treatment,22:25:cancer,,46:61:treatment
|
No prior therapy for MCL, except < 1 week of steroid therapy for symptom control
| 3
|
[
"No",
"prior",
"therapy",
"for",
"MCL",
",",
"except",
"<",
"1",
"week",
"of",
"steroid",
"therapy",
"for",
"symptom",
"control"
] |
[
0,
1,
1,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02957149
|
1:10:treatment,20:27:treatment,45:53:treatment,55:69:treatment,73:101:treatment
|
Treatment prior to surgery with any form of hormones, anti-androgens or androgen deprivation therapy
| 3
|
[
"Treatment",
"prior",
"to",
"surgery",
"with",
"any",
"form",
"of",
"hormones",
",",
"anti-androgens",
"or",
"androgen",
"deprivation",
"therapy"
] |
[
1,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT02163317
|
22:25:treatment
|
unable to undergo an MRI with contrast
| 3
|
[
"unable",
"to",
"undergo",
"an",
"MRI",
"with",
"contrast"
] |
[
0,
0,
0,
0,
1,
0,
0
] |
NCT02553941
|
18:52:chronic_disease,68:91:chronic_disease,95:118:chronic_disease
|
Known history of human immunodeficiency virus (HIV) or active with hepatitis C virus (HCV) or hepatitis B virus (HBV)
| 3
|
[
"Known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"active",
"with",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")",
"or",
"hepatitis",
"B",
"virus",
"(",
"HBV",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02748577
|
1:35:chronic_disease
|
Severe clinical depression/anxiety
| 3
|
[
"Severe",
"clinical",
"depression/anxiety"
] |
[
2,
2,
2
] |
NCT02555280
|
21:53:chronic_disease
|
patients with up to Grade I stable spondylolisthesis at the adjacent level
| 3
|
[
"patients",
"with",
"up",
"to",
"Grade",
"I",
"stable",
"spondylolisthesis",
"at",
"the",
"adjacent",
"level"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02451423
|
21:44:chronic_disease,46:70:chronic_disease,106:140:chronic_disease
|
Patients with known coronary artery disease, congestive heart failure not meeting the above criteria, or left ventricular ejection fraction
| 3
|
[
"Patients",
"with",
"known",
"coronary",
"artery",
"disease",
",",
"congestive",
"heart",
"failure",
"not",
"meeting",
"the",
"above",
"criteria",
",",
"or",
"left",
"ventricular",
"ejection",
"fraction"
] |
[
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02541565
|
14:45:treatment,47:90:treatment,92:135:treatment,137:184:treatment,196:201:treatment,207:273:treatment,265:273:treatment,285:295:treatment,321:370:treatment
|
Has received prior therapy with an anti-PD-1, anti-programmed cell death ligand 1 (PD-L1), anti-programmed cell death ligand 2 (PD-L2), anti-tumor necrosis factor receptor superfamily, member 9 (CD137), or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways)
| 3
|
[
"Has",
"received",
"prior",
"therapy",
"with",
"an",
"anti-PD-1",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"1",
"(",
"PD-L1",
")",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"2",
"(",
"PD-L2",
")",
",",
"anti-tumor",
"necrosis",
"factor",
"receptor",
"superfamily",
",",
"member",
"9",
"(",
"CD137",
")",
",",
"or",
"anti-cytotoxic",
"T-lymphocyte-associated",
"antigen-4",
"(",
"CTLA-4",
")",
"antibody",
"(",
"including",
"ipilimumab",
"or",
"any",
"other",
"antibody",
"or",
"drug",
"specifically",
"targeting",
"T-cell",
"co-stimulation",
"or",
"checkpoint",
"pathways",
")"
] |
[
0,
0,
1,
1,
1,
1,
1,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1,
1,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT02098876
|
1:20:chronic_disease,,
|
renal insufficiency as defined as an estimated GFR < 30 ml/min/1.73m2
| 3
|
[
"renal",
"insufficiency",
"as",
"defined",
"as",
"an",
"estimated",
"GFR",
"<",
"30",
"ml/min/1.73m2"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01773395
|
1:28:treatment
|
Prior allogeneic transplant
| 3
|
[
"Prior",
"allogeneic",
"transplant"
] |
[
1,
1,
1
] |
NCT02130687
|
1:5:chronic_disease
|
T2DM
| 3
|
[
"T2DM"
] |
[
2
] |
NCT01983462
|
15:37:chronic_disease,45:57:chronic_disease,59:65:chronic_disease,67:80:chronic_disease,82:104:chronic_disease,106:120:chronic_disease,123:129:chronic_disease,133:148:chronic_disease,153:180:chronic_disease
|
No history of cardiovascular disease (e.g., heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy), Type 1 or Type 2 diabetes, or peripheral arterial disease
| 3
|
[
"No",
"history",
"of",
"cardiovascular",
"disease",
"(",
"e.g.",
",",
"heart",
"attack",
",",
"stroke",
",",
"heart",
"failure",
",",
"valvular",
"heart",
"disease",
",",
"cardiomyopathy",
")",
",",
"Type",
"1",
"or",
"Type",
"2",
"diabetes",
",",
"or",
"peripheral",
"arterial",
"disease"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02178709
|
32:41:treatment
|
Inability to receive a port or PICC line
| 3
|
[
"Inability",
"to",
"receive",
"a",
"port",
"or",
"PICC",
"line"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02327312
|
1:28:chronic_disease
|
Active corneal inflammation
| 3
|
[
"Active",
"corneal",
"inflammation"
] |
[
2,
2,
2
] |
NCT02245841
|
1:10:treatment
|
sirolimus
| 3
|
[
"sirolimus"
] |
[
1
] |
NCT02523443
|
21:50:treatment,114:138:cancer,170:201:treatment,211:231:treatment,235:255:treatment,306:323:treatment,325:344:chronic_disease,346:356:chronic_disease,361:387:treatment
|
Patients undergoing open elective liver resection for primary liver pathology (benign or malignant) or secondary metastatic liver disease, including patients undergoing concomitant surgical procedures (such as colorectal resection or debulking procedures), with no contraindication to the insertion of an epidural catheter (localized infection, septicemia, or pre-operative coagulopathy)
| 3
|
[
"Patients",
"undergoing",
"open",
"elective",
"liver",
"resection",
"for",
"primary",
"liver",
"pathology",
"(",
"benign",
"or",
"malignant",
")",
"or",
"secondary",
"metastatic",
"liver",
"disease",
",",
"including",
"patients",
"undergoing",
"concomitant",
"surgical",
"procedures",
"(",
"such",
"as",
"colorectal",
"resection",
"or",
"debulking",
"procedures",
")",
",",
"with",
"no",
"contraindication",
"to",
"the",
"insertion",
"of",
"an",
"epidural",
"catheter",
"(",
"localized",
"infection",
",",
"septicemia",
",",
"or",
"pre-operative",
"coagulopathy",
")"
] |
[
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
2,
0,
2,
0,
0,
1,
1,
0
] |
NCT02624765
|
24:48:chronic_disease
|
History of significant maternal heart condition
| 3
|
[
"History",
"of",
"significant",
"maternal",
"heart",
"condition"
] |
[
0,
0,
0,
2,
2,
2
] |
NCT02346201
|
24:33:chronic_disease
|
Clinically significant delusions for which either
| 3
|
[
"Clinically",
"significant",
"delusions",
"for",
"which",
"either"
] |
[
0,
0,
2,
0,
0,
0
] |
NCT01505569
|
22:34:treatment
|
Patients may receive transfusions as necessary
| 3
|
[
"Patients",
"may",
"receive",
"transfusions",
"as",
"necessary"
] |
[
0,
0,
0,
1,
0,
0
] |
NCT02243813
|
197:215:treatment
|
Agree to consume approximately the same amount of caffeine-containing beverage (e.g., coffee, tea) that he/she consumes on a usual morning, before arriving at the research unit on the mornings of psilocybin session days
| 3
|
[
"Agree",
"to",
"consume",
"approximately",
"the",
"same",
"amount",
"of",
"caffeine-containing",
"beverage",
"(",
"e.g.",
",",
"coffee",
",",
"tea",
")",
"that",
"he/she",
"consumes",
"on",
"a",
"usual",
"morning",
",",
"before",
"arriving",
"at",
"the",
"research",
"unit",
"on",
"the",
"mornings",
"of",
"psilocybin",
"session",
"days"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02535832
|
1:30:treatment
|
chronic anticoagulant therapy
| 3
|
[
"chronic",
"anticoagulant",
"therapy"
] |
[
1,
1,
1
] |
NCT01730118
|
22:36:cancer,40:54:cancer,70:75:cancer,104:120:cancer,160:176:chronic_disease,180:187:treatment,191:200:treatment,261:272:chronic_disease,
|
Patients with active CNS metastases or leptomeningeal involvement by tumor (patients with a history of brain metastases who have been successfully treated for brain metastasis by surgery or radiation and who have not had any evidence of the new or progressive CNS disease fot more than 12 months are eligible)
| 3
|
[
"Patients",
"with",
"active",
"CNS",
"metastases",
"or",
"leptomeningeal",
"involvement",
"by",
"tumor",
"(",
"patients",
"with",
"a",
"history",
"of",
"brain",
"metastases",
"who",
"have",
"been",
"successfully",
"treated",
"for",
"brain",
"metastasis",
"by",
"surgery",
"or",
"radiation",
"and",
"who",
"have",
"not",
"had",
"any",
"evidence",
"of",
"the",
"new",
"or",
"progressive",
"CNS",
"disease",
"fot",
"more",
"than",
"12",
"months",
"are",
"eligible",
")"
] |
[
0,
0,
0,
2,
2,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346201
|
18:27:chronic_disease
|
the frequency of delusions as assessed by the NPI is 'Very frequently'
| 3
|
[
"the",
"frequency",
"of",
"delusions",
"as",
"assessed",
"by",
"the",
"NPI",
"is",
"'Very",
"frequently",
"'"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01920061
|
17:28:treatment,32:41:treatment,57:65:treatment,69:87:treatment
|
Prior platinum (carboplatin or cisplatin) in either the adjuvant or metastatic setting
| 3
|
[
"Prior",
"platinum",
"(",
"carboplatin",
"or",
"cisplatin",
")",
"in",
"either",
"the",
"adjuvant",
"or",
"metastatic",
"setting"
] |
[
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT02356861
|
22:37:chronic_disease,46:59:chronic_disease,71:81:chronic_disease
|
Presence of a severe mental disorder such as schizophrenia, or severe depression
| 3
|
[
"Presence",
"of",
"a",
"severe",
"mental",
"disorder",
"such",
"as",
"schizophrenia",
",",
"or",
"severe",
"depression"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
2,
0,
0,
0,
2
] |
NCT02535533
|
11:17:cancer,,111:121:cancer,125:150:cancer,152:178:cancer,164:171:cancer,191:222:cancer,224:230:cancer,265:280:cancer,
|
Any other cancer from which the patient has been disease-free for less than 5 years (except treated and cured basal-cell or squamous-cell skin cancer, superficial bladder cancer, or treated carcinoma in situ of the cervix, breast, or bladder and treated localized prostate cancer with undetectable PSA for 2 years)
| 3
|
[
"Any",
"other",
"cancer",
"from",
"which",
"the",
"patient",
"has",
"been",
"disease-free",
"for",
"less",
"than",
"5",
"years",
"(",
"except",
"treated",
"and",
"cured",
"basal-cell",
"or",
"squamous-cell",
"skin",
"cancer",
",",
"superficial",
"bladder",
"cancer",
",",
"or",
"treated",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"breast",
",",
"or",
"bladder",
"and",
"treated",
"localized",
"prostate",
"cancer",
"with",
"undetectable",
"PSA",
"for",
"2",
"years",
")"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03159754
|
10:22:chronic_disease
|
Previous appendicitis
| 3
|
[
"Previous",
"appendicitis"
] |
[
0,
2
] |
NCT02508467
|
25:34:treatment
|
does not have access to sorafenib
| 3
|
[
"does",
"not",
"have",
"access",
"to",
"sorafenib"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02132598
|
17:63:treatment,,104:116:treatment,124:137:treatment,139:148:treatment,150:163:treatment,165:174:treatment
|
The subject has received enzyme-inducing anti-epileptic agents within 2 weeks before the first dose of cabozantinib (e.g., carbamazepine, phenytoin, phenobarbital, primidone)
| 3
|
[
"The",
"subject",
"has",
"received",
"enzyme-inducing",
"anti-epileptic",
"agents",
"within",
"2",
"weeks",
"before",
"the",
"first",
"dose",
"of",
"cabozantinib",
"(",
"e.g.",
",",
"carbamazepine",
",",
"phenytoin",
",",
"phenobarbital",
",",
"primidone",
")"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT03170856
|
205:228:chronic_disease
|
Concussion will be diagnosed by board-certified sports medicine physicians, and defined as a direct or indirect blow to the head, face, neck, or elsewhere that manifests with the presence of symptoms and neurological impairment
| 3
|
[
"Concussion",
"will",
"be",
"diagnosed",
"by",
"board-certified",
"sports",
"medicine",
"physicians",
",",
"and",
"defined",
"as",
"a",
"direct",
"or",
"indirect",
"blow",
"to",
"the",
"head",
",",
"face",
",",
"neck",
",",
"or",
"elsewhere",
"that",
"manifests",
"with",
"the",
"presence",
"of",
"symptoms",
"and",
"neurological",
"impairment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03086369
|
31:45:treatment
|
Received prior treatment with nab-paclitaxel
| 3
|
[
"Received",
"prior",
"treatment",
"with",
"nab-paclitaxel"
] |
[
0,
0,
0,
0,
1
] |
NCT01730118
|
12:23:treatment,,,59:80:cancer,85:95:cancer,120:130:treatment,
|
Cumulative doxorubicin dose >= 400mg/m^2 (>450 mg/m^2 for malignant soft tissue and bone tumor patients) or cumulative epirubicin dose >= 800mg/m^2
| 3
|
[
"Cumulative",
"doxorubicin",
"dose",
">",
"=",
"400mg/m^2",
"(",
">",
"450",
"mg/m^2",
"for",
"malignant",
"soft",
"tissue",
"and",
"bone",
"tumor",
"patients",
")",
"or",
"cumulative",
"epirubicin",
"dose",
">",
"=",
"800mg/m^2"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT03006302
|
8:16:treatment
|
Use of warfarin
| 3
|
[
"Use",
"of",
"warfarin"
] |
[
0,
0,
1
] |
NCT02779556
|
1:33:chronic_disease
|
uncorrectable visual impairments
| 3
|
[
"uncorrectable",
"visual",
"impairments"
] |
[
2,
2,
2
] |
NCT01696734
|
1:14:chronic_disease
|
gastroparesis
| 3
|
[
"gastroparesis"
] |
[
2
] |
NCT02243813
|
1:27:chronic_disease,39:56:treatment,83:95:chronic_disease
|
Insulin-dependent diabetes; if taking oral hypoglycemic agent, then no history of hypoglycemia
| 3
|
[
"Insulin-dependent",
"diabetes",
";",
"if",
"taking",
"oral",
"hypoglycemic",
"agent",
",",
"then",
"no",
"history",
"of",
"hypoglycemia"
] |
[
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2
] |
NCT02682147
|
1:14:chronic_disease
|
Heart disease
| 3
|
[
"Heart",
"disease"
] |
[
2,
2
] |
NCT02048722
|
38:40:treatment,38:44:treatment,88:96:treatment,106:125:treatment,154:174:treatment
|
infrequent bleeding or elevations in PT-INR have been reported in some subjects taking warfarin while on regorafenib therapy; therefore, subjects taking concomitant warfarin should be monitored regularly for changes in PT, PT-INR or clinical bleeding episodes
| 3
|
[
"infrequent",
"bleeding",
"or",
"elevations",
"in",
"PT-INR",
"have",
"been",
"reported",
"in",
"some",
"subjects",
"taking",
"warfarin",
"while",
"on",
"regorafenib",
"therapy",
";",
"therefore",
",",
"subjects",
"taking",
"concomitant",
"warfarin",
"should",
"be",
"monitored",
"regularly",
"for",
"changes",
"in",
"PT",
",",
"PT-INR",
"or",
"clinical",
"bleeding",
"episodes"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02048371
|
44:59:treatment
|
Subject must be able to swallow and retain oral medication
| 3
|
[
"Subject",
"must",
"be",
"able",
"to",
"swallow",
"and",
"retain",
"oral",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02649790
|
13:37:cancer
|
Higher risk Myelodysplastic Syndrome
| 3
|
[
"Higher",
"risk",
"Myelodysplastic",
"Syndrome"
] |
[
0,
0,
3,
3
] |
NCT02943915
|
,18:58:treatment
|
< 3 months since previous intensive gait training regimen
| 3
|
[
"<",
"3",
"months",
"since",
"previous",
"intensive",
"gait",
"training",
"regimen"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT01983228
|
22:31:chronic_disease,42:53:chronic_disease,69:74:chronic_disease,104:120:chronic_disease
|
patients with active psychotic symptoms, suicidality, and/or active manic episode or poorly controlled bipolar disorder
| 3
|
[
"patients",
"with",
"active",
"psychotic",
"symptoms",
",",
"suicidality",
",",
"and/or",
"active",
"manic",
"episode",
"or",
"poorly",
"controlled",
"bipolar",
"disorder"
] |
[
0,
0,
0,
2,
0,
0,
2,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2
] |
NCT02436070
|
1:30:chronic_disease
|
Co-morbid respiratory disease
| 3
|
[
"Co-morbid",
"respiratory",
"disease"
] |
[
2,
2,
2
] |
NCT02232516
|
7:24:treatment
|
these topical therapies should be stopped at time of registration
| 3
|
[
"these",
"topical",
"therapies",
"should",
"be",
"stopped",
"at",
"time",
"of",
"registration"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02008136
|
8:27:chronic_disease,29:37:chronic_disease,41:49:chronic_disease
|
Severe psychiatric illness, dementia or delirium
| 3
|
[
"Severe",
"psychiatric",
"illness",
",",
"dementia",
"or",
"delirium"
] |
[
0,
2,
2,
0,
2,
0,
2
] |
NCT01795313
|
,,62:75:treatment,
|
Patients must be on no more than 0.1 mg/kg/day, max 4 mg/day dexamethasone for at least one week before study registration
| 3
|
[
"Patients",
"must",
"be",
"on",
"no",
"more",
"than",
"0.1",
"mg/kg/day",
",",
"max",
"4",
"mg/day",
"dexamethasone",
"for",
"at",
"least",
"one",
"week",
"before",
"study",
"registration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02181478
|
1:14:cancer
|
High-risk CR1 including
| 3
|
[
"High-risk",
"CR1",
"including"
] |
[
3,
3,
0
] |
NCT02830360
|
30:55:chronic_disease
|
Are known to have protruding left ventricular thrombus or mechanical aortic and mitral valves
| 3
|
[
"Are",
"known",
"to",
"have",
"protruding",
"left",
"ventricular",
"thrombus",
"or",
"mechanical",
"aortic",
"and",
"mitral",
"valves"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02273375
|
1:23:treatment
|
Prior Systemic Therapy
| 3
|
[
"Prior",
"Systemic",
"Therapy"
] |
[
1,
1,
1
] |
NCT01589263
|
5:32:treatment,43:81:treatment,86:89:chronic_disease
|
Any prior surgical intervention or use of 5-alpha-reductase medical intervention for BPH
| 3
|
[
"Any",
"prior",
"surgical",
"intervention",
"or",
"use",
"of",
"5-alpha-reductase",
"medical",
"intervention",
"for",
"BPH"
] |
[
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
2
] |
NCT01954316
|
55:65:chronic_disease
|
Have active, acute, or chronic clinically significant infections
| 3
|
[
"Have",
"active",
",",
"acute",
",",
"or",
"chronic",
"clinically",
"significant",
"infections"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT01681264
|
44:52:treatment,61:69:treatment,71:93:chronic_disease
|
subjects will be warned of side effects of morphine such as sedation, respiratory depression at the enrollment
| 3
|
[
"subjects",
"will",
"be",
"warned",
"of",
"side",
"effects",
"of",
"morphine",
"such",
"as",
"sedation",
",",
"respiratory",
"depression",
"at",
"the",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
2,
2,
0,
0,
0
] |
NCT02979327
|
26:37:treatment
|
Prior history of regular amphetamine use
| 3
|
[
"Prior",
"history",
"of",
"regular",
"amphetamine",
"use"
] |
[
0,
0,
0,
0,
1,
0
] |
NCT02508311
|
1:22:treatment
|
Ventilator Dependence
| 3
|
[
"Ventilator",
"Dependence"
] |
[
1,
1
] |
NCT01366612
|
23:43:cancer,47:82:cancer,87:105:cancer,110:134:cancer,141:157:treatment
|
complete resection of basal cell carcinoma or squamous cell carcinoma of the skin, an in situ malignancy, or low-risk prostate cancer after curative therapy
| 3
|
[
"complete",
"resection",
"of",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"an",
"in",
"situ",
"malignancy",
",",
"or",
"low-risk",
"prostate",
"cancer",
"after",
"curative",
"therapy"
] |
[
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
3,
3,
3,
0,
1,
1
] |
NCT02832167
|
10:36:treatment,27:36:treatment,49:59:cancer,104:110:cancer
|
Received standard of care treatment for primary malignancy and standard of care treatment for relapsed cancer
| 3
|
[
"Received",
"standard",
"of",
"care",
"treatment",
"for",
"primary",
"malignancy",
"and",
"standard",
"of",
"care",
"treatment",
"for",
"relapsed",
"cancer"
] |
[
0,
1,
1,
1,
1,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02163317
|
1:26:treatment,36:89:treatment,97:106:treatment,108:118:treatment,123:139:treatment,147:156:treatment,159:173:treatment,181:190:treatment,192:204:treatment,207:216:treatment,224:248:treatment,254:287:treatment
|
Previous hormonal therapy, such as luteinizing hormone-releasing hormone (LHRH) agonists (e.g., goserelin, leuprolide) or LHRH antagonists (e.g., degarelix), anti-androgens (e.g., flutamide, bicalutamide), estrogens (e.g., diethylstilbestrol [DES]), or surgical castration (orchiectomy)
| 3
|
[
"Previous",
"hormonal",
"therapy",
",",
"such",
"as",
"luteinizing",
"hormone-releasing",
"hormone",
"(",
"LHRH",
")",
"agonists",
"(",
"e.g.",
",",
"goserelin",
",",
"leuprolide",
")",
"or",
"LHRH",
"antagonists",
"(",
"e.g.",
",",
"degarelix",
")",
",",
"anti-androgens",
"(",
"e.g.",
",",
"flutamide",
",",
"bicalutamide",
")",
",",
"estrogens",
"(",
"e.g.",
",",
"diethylstilbestrol",
"[",
"DES",
"]",
")",
",",
"or",
"surgical",
"castration",
"(",
"orchiectomy",
")"
] |
[
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT02796209
|
15:36:chronic_disease
|
Patients with narrow angle glaucoma
| 3
|
[
"Patients",
"with",
"narrow",
"angle",
"glaucoma"
] |
[
0,
0,
2,
2,
2
] |
NCT02004028
|
25:44:chronic_disease
|
Subjects with confirmed Hepatitis A, B or C
| 3
|
[
"Subjects",
"with",
"confirmed",
"Hepatitis",
"A",
",",
"B",
"or",
"C"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0
] |
NCT01618357
|
15:23:cancer,28:50:cancer,54:76:cancer
|
Patients with squamous, or metaplastic carcinomas or sarcomas of the breast
| 3
|
[
"Patients",
"with",
"squamous",
",",
"or",
"metaplastic",
"carcinomas",
"or",
"sarcomas",
"of",
"the",
"breast"
] |
[
0,
0,
3,
0,
0,
3,
3,
0,
3,
3,
3,
3
] |
NCT02530034
|
25:38:cancer
|
patients with high-risk myelofibrosis
| 3
|
[
"patients",
"with",
"high-risk",
"myelofibrosis"
] |
[
0,
0,
0,
3
] |
NCT02771626
|
30:47:treatment
|
Some cohort exceptions allow anti-PD-1 therapy
| 3
|
[
"Some",
"cohort",
"exceptions",
"allow",
"anti-PD-1",
"therapy"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT01988246
|
12:55:chronic_disease
|
Absence of clinically significant macular edema (CSME) in the study eye as detected by clinical exam
| 3
|
[
"Absence",
"of",
"clinically",
"significant",
"macular",
"edema",
"(",
"CSME",
")",
"in",
"the",
"study",
"eye",
"as",
"detected",
"by",
"clinical",
"exam"
] |
[
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02740543
|
1:30:treatment,
|
Oral corticosteroid treatment within the last 4 weeks
| 3
|
[
"Oral",
"corticosteroid",
"treatment",
"within",
"the",
"last",
"4",
"weeks"
] |
[
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02332850
|
39:67:chronic_disease
|
Patients with evidence of significant mucosal or internal bleeding
| 3
|
[
"Patients",
"with",
"evidence",
"of",
"significant",
"mucosal",
"or",
"internal",
"bleeding"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT01373099
|
18:40:allergy_name,42:52:allergy_name,56:66:allergy_name
|
Known allergy to polymethylmethacrylate, tobramycin or vancomycin
| 3
|
[
"Known",
"allergy",
"to",
"polymethylmethacrylate",
",",
"tobramycin",
"or",
"vancomycin"
] |
[
0,
0,
0,
4,
0,
4,
0,
4
] |
NCT02836899
|
,,45:61:treatment,
|
Left ventricular ejection fraction < 30% by echocardiography obtained within three months of enrollment
| 3
|
[
"Left",
"ventricular",
"ejection",
"fraction",
"<",
"30",
"%",
"by",
"echocardiography",
"obtained",
"within",
"three",
"months",
"of",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02124772
|
70:81:chronic_disease
|
a history or evidence of current clinically significant uncontrolled arrhythmias (clarification
| 3
|
[
"a",
"history",
"or",
"evidence",
"of",
"current",
"clinically",
"significant",
"uncontrolled",
"arrhythmias",
"(",
"clarification"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT03040778
|
8:29:chronic_disease
|
recent myocardial infarction
| 3
|
[
"recent",
"myocardial",
"infarction"
] |
[
0,
2,
2
] |
NCT03026816
|
1:27:treatment,
|
Botulinum toxin injections in the previous 6 months
| 3
|
[
"Botulinum",
"toxin",
"injections",
"in",
"the",
"previous",
"6",
"months"
] |
[
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT01054196
|
23:38:treatment,,
|
Patients who have had myeloma therapy within 14 days prior to entering the study or those who have not recovered from adverse events due to agents administered more than 2 weeks earlier
| 3
|
[
"Patients",
"who",
"have",
"had",
"myeloma",
"therapy",
"within",
"14",
"days",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered",
"from",
"adverse",
"events",
"due",
"to",
"agents",
"administered",
"more",
"than",
"2",
"weeks",
"earlier"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01313533
|
1:21:chronic_disease
|
Hypercoaguable state
| 3
|
[
"Hypercoaguable",
"state"
] |
[
2,
2
] |
NCT02875405
|
10:40:treatment
|
need for hypothermic circulatory arrest
| 3
|
[
"need",
"for",
"hypothermic",
"circulatory",
"arrest"
] |
[
0,
0,
1,
1,
1
] |
NCT02393885
|
1:16:chronic_disease,20:37:chronic_disease,44:85:chronic_disease,89:130:chronic_disease
|
Blood dyscrasia or clotting disorder (i.e. Idiopathic Thrombocytopenic Purpura [ITP] or Thrombotic Thrombocytopenic Purpura [TTP])
| 3
|
[
"Blood",
"dyscrasia",
"or",
"clotting",
"disorder",
"(",
"i.e",
".",
"Idiopathic",
"Thrombocytopenic",
"Purpura",
"[",
"ITP",
"]",
"or",
"Thrombotic",
"Thrombocytopenic",
"Purpura",
"[",
"TTP",
"]",
")"
] |
[
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02076906
|
10:17:treatment,30:37:treatment,39:56:treatment,58:70:treatment
|
Curative therapy may include surgery, radiation therapy, chemotherapy, or any combination of these modalities
| 3
|
[
"Curative",
"therapy",
"may",
"include",
"surgery",
",",
"radiation",
"therapy",
",",
"chemotherapy",
",",
"or",
"any",
"combination",
"of",
"these",
"modalities"
] |
[
0,
1,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02232516
|
39:43:cancer
|
Histologically confirmed diagnosis of PTCL (using the most recent edition of the World Health Organization [WHO] Classification of Tumors of Hematopoietic and Lymphoid Tissues as guidance)
| 3
|
[
"Histologically",
"confirmed",
"diagnosis",
"of",
"PTCL",
"(",
"using",
"the",
"most",
"recent",
"edition",
"of",
"the",
"World",
"Health",
"Organization",
"[",
"WHO",
"]",
"Classification",
"of",
"Tumors",
"of",
"Hematopoietic",
"and",
"Lymphoid",
"Tissues",
"as",
"guidance",
")"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02901314
|
1:22:chronic_disease
|
Chronic renal failure
| 3
|
[
"Chronic",
"renal",
"failure"
] |
[
2,
2,
2
] |
NCT02544880
|
1:16:treatment
|
Salvage surgery is not recommended as per NCCN guidelines, or after multidisciplinary treatment evaluation, including those with surgically unresectable disease at primary site or regional lymph nodes
| 3
|
[
"Salvage",
"surgery",
"is",
"not",
"recommended",
"as",
"per",
"NCCN",
"guidelines",
",",
"or",
"after",
"multidisciplinary",
"treatment",
"evaluation",
",",
"including",
"those",
"with",
"surgically",
"unresectable",
"disease",
"at",
"primary",
"site",
"or",
"regional",
"lymph",
"nodes"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02446236
|
,50:54:chronic_disease
|
Presence of at least one lymph node evaluable or mass measurable for response
| 3
|
[
"Presence",
"of",
"at",
"least",
"one",
"lymph",
"node",
"evaluable",
"or",
"mass",
"measurable",
"for",
"response"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0
] |
NCT02587962
|
62:87:cancer,145:152:treatment,249:261:cancer,270:274:cancer
|
Patients must have histologically or cytologically confirmed small cell lung carcinoma that is locally advanced or metastatic with no available therapy options that are known to provide clinical benefit per institutional standard of care. (various solid tumors cohort, SCLC group only)
| 3
|
[
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"small",
"cell",
"lung",
"carcinoma",
"that",
"is",
"locally",
"advanced",
"or",
"metastatic",
"with",
"no",
"available",
"therapy",
"options",
"that",
"are",
"known",
"to",
"provide",
"clinical",
"benefit",
"per",
"institutional",
"standard",
"of",
"care",
".",
"(",
"various",
"solid",
"tumors",
"cohort",
",",
"SCLC",
"group",
"only",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
0,
0
] |
NCT03078192
|
21:48:treatment,67:70:chronic_disease,80:87:chronic_disease,91:108:chronic_disease,113:122:treatment
|
Patients undergoing right heart catheterization for evaluation of PAH or other cardiac or pulmonary disease for MRI scans
| 3
|
[
"Patients",
"undergoing",
"right",
"heart",
"catheterization",
"for",
"evaluation",
"of",
"PAH",
"or",
"other",
"cardiac",
"or",
"pulmonary",
"disease",
"for",
"MRI",
"scans"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
2,
0,
0,
2,
0,
2,
2,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.